Catalent Pharma Solutions

是其中之一......

• Fortune 500 (#662);
• Russell 3000;
• S&P 500.

Catalent Pharma Solutions 是一家在股票代码 CTLT (US) 下上市的公司。

Catalent Pharma Solutions 在 2 个国家有直接业务。

Catalent Pharma Solutions 拥有 3家子公司，其中包括 Catalent Biologics、Catalent Cell & Gene Therapy 和 Catalent Pharma Germany。

他们在：

• 医疗设备50%
• 生物技术50%

涉及Catalent Pharma Solutions的并购和融资。

• Novo Holdings has announced the acquisition of Catalent Pharma Solutions  (公布2024二月8号).
• Catalent Pharma Solutions 已收购 Metrics Contract Services (公布2022八月12号).

查看带有其 57 名主要高管的组织结构图

Catalent Pharma Solutions 搜索最多的简介

• Alessandro Maselli, President and Chief Executive Officer
• Jack Stahl, Board Member and Lead Director
• Michael Barber, Board Member

高管在Catalent Pharma Solutions变化

• John Greisch 曾任 Director, 现升职为 Executive Chairman of the Board  (新闻发布的2023八月30号).
• Frank D'Amelio已作为Director加入公司  (新闻发布的2023八月30号).
• Steven Barg已作为Director加入公司  (新闻发布的2023八月30号).

更多的变化在％s

创建提醒
跟踪 Catalent Pharma Solutions 的高管变动

Catalent Pharma Solutions 拥有 983 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• Medigus将在Apr 12, 2024将其名称改为Xylo Technologies。 (公布2024四月12号).
• Johnson & Johnson has announced the acquisition of Shockwave Medical  (公布2024四月6号).
• Carlsmed 刚刚宣布为 52 筹款数百万美元。 (公布2024三月22号).

医疗设备 行业的其他推荐联系人

• Thermo Fisher Scientific 企业 Marc Casper - Chairman of the Board, President and Chief Executive Officer
• Bruker 企业 Robert Rosenthal - Director
• DexCom 企业 Don Abbey - Executive Vice President, Global Business Services, Information Technology, Quality and Regulatory Affairs

了解更多有关医疗设备行业的信息 >

Catalent Pharma Solutions 的最新新闻稿

• Catalent Publishes Fifth Annual Corporate Responsibility Report
• Catalent Adds Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston Facility
• Novo Holdings to Acquire Catalent | Catalent Pharma Solutions
• Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
• Catalent Appoints David McErlane as Biologics Segment Leader
• Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resource Officer
• Catalent Appoints New Senior Vice President & Chief Financial Officer
• Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics
• Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities
• Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development
• View more press releases Close

关于 Catalent Pharma Solutions 的社交媒体

• Catalent Pharma Solutions 在 维基百科、谷歌新闻 和 雅虎财经
• Catalent Pharma Solutions 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Alessandro Maselli

致电Catalent Pharma Solutions，电话：+1 732...

查看组织结构图

Register to receive your alert

报告错误